Log in

NYSE:LTHMLivent Stock Price, Forecast & News

$6.18
-0.04 (-0.64 %)
(As of 07/13/2020 04:00 PM ET)
Add
Compare
Today's Range
$6.10
Now: $6.18
$6.42
50-Day Range
$5.74
MA: $6.85
$8.32
52-Week Range
$3.95
Now: $6.18
$12.29
Volume3.34 million shs
Average Volume3.74 million shs
Market Capitalization$903.39 million
P/E Ratio28.09
Dividend YieldN/A
Beta2.07
Livent Corporation manufactures and sells performance lithium compounds that are used primarily in energy storage, specialty polymers, and chemical synthesis application. The company offers lithium compounds for use in applications that have specific performance requirements, including battery-grade lithium hydroxide for use in high performance lithium-ion batteries; and supplies butyllithium, which is used as a synthesizer in the production of polymers and pharmaceutical products, as well as a range of specialty lithium compounds, including high purity lithium metal, which is used in the production of lightweight materials for aerospace applications and non-rechargeable batteries. Livent Corporation was incorporated in 2018 and is headquartered in Philadelphia, Pennsylvania.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 1.0Community Rank: 2.0Dividend Strength: 0.0Insider Behavior: 1.0Valuation: 1.9 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.18 out of 5 stars


Industry, Sector and Symbol

Industry Chemicals & allied products
Sub-IndustryN/A
CUSIPN/A
CIKN/A
Phone215-299-6000

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$388.40 million
Cash Flow$0.56 per share
Book Value$3.73 per share

Profitability

Net Income$50.20 million

Miscellaneous

EmployeesN/A
Market Cap$903.39 million
Next Earnings Date8/6/2020 (Confirmed)
OptionableNot Optionable

Receive LTHM News and Ratings via Email

Sign-up to receive the latest news and ratings for LTHM and its competitors with MarketBeat's FREE daily newsletter.

Livent (NYSE:LTHM) Frequently Asked Questions

How has Livent's stock been impacted by COVID-19 (Coronavirus)?

Livent's stock was trading at $7.47 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, LTHM stock has decreased by 17.3% and is now trading at $6.18. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Livent?

10 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Livent in the last year. There are currently 1 sell rating, 8 hold ratings and 1 buy rating for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for Livent.

When is Livent's next earnings date?

Livent is scheduled to release its next quarterly earnings announcement on Thursday, August 6th 2020. View our earnings forecast for Livent.

How were Livent's earnings last quarter?

Livent Corporation (NYSE:LTHM) issued its quarterly earnings data on Monday, May, 11th. The company reported $0.02 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.04 by $0.02. The firm had revenue of $68.50 million for the quarter, compared to the consensus estimate of $91.77 million. Livent had a return on equity of 8.52% and a net margin of 8.76%. The business's quarterly revenue was down 30.3% compared to the same quarter last year. During the same quarter in the prior year, the company earned $0.12 earnings per share. View Livent's earnings history.

What price target have analysts set for LTHM?

10 Wall Street analysts have issued 12-month target prices for Livent's stock. Their forecasts range from $5.00 to $9.00. On average, they anticipate Livent's share price to reach $6.64 in the next year. This suggests a possible upside of 7.5% from the stock's current price. View analysts' price targets for Livent.

Has Livent been receiving favorable news coverage?

News headlines about LTHM stock have trended somewhat positive recently, InfoTrie reports. InfoTrie identifies positive and negative media coverage by monitoring more than six thousand news and blog sources. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores closest to five being the most favorable. Livent earned a news impact score of 1.8 on InfoTrie's scale. They also assigned media headlines about the company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an impact on the company's share price in the near future. View the latest news about Livent.

Are investors shorting Livent?

Livent saw a increase in short interest during the month of June. As of June 15th, there was short interest totaling 19,160,000 shares, an increase of 8.1% from the May 31st total of 17,730,000 shares. Based on an average trading volume of 2,110,000 shares, the days-to-cover ratio is presently 9.1 days. Approximately 13.2% of the shares of the stock are short sold. View Livent's Current Options Chain.

Who are some of Livent's key competitors?

What other stocks do shareholders of Livent own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Livent investors own include Albemarle (ALB), Walt Disney (DIS), Alibaba Group (BABA), AT&T (T), Northrop Grumman (NOC), NVIDIA (NVDA), AbbVie (ABBV), Freeport-McMoRan (FCX), CVS Health (CVS) and General Electric (GE).

When did Livent IPO?

(LTHM) raised $380 million in an IPO on Thursday, October 11th 2018. The company issued 20,000,000 shares at a price of $18.00-$20.00 per share. BofA Merrill Lynch, Goldman Sach and Credit Suisse acted as the underwriters for the IPO and Citigroup, Loop Capital Markets and Nomura were co-managers.

What is Livent's stock symbol?

Livent trades on the New York Stock Exchange (NYSE) under the ticker symbol "LTHM."

Who are Livent's major shareholders?

Livent's stock is owned by many different institutional and retail investors. Top institutional investors include Robecosam AG (0.89%) and FNY Investment Advisers LLC (0.04%). Company insiders that own Livent stock include Nicholas Pfeiffer and Steven T Merkt. View institutional ownership trends for Livent.

Which major investors are selling Livent stock?

LTHM stock was sold by a variety of institutional investors in the last quarter, including Robecosam AG. View insider buying and selling activity for Livent.

Which major investors are buying Livent stock?

LTHM stock was purchased by a variety of institutional investors in the last quarter, including FNY Investment Advisers LLC. Company insiders that have bought Livent stock in the last two years include Nicholas Pfeiffer, and Steven T Merkt. View insider buying and selling activity for Livent.

How do I buy shares of Livent?

Shares of LTHM can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Livent's stock price today?

One share of LTHM stock can currently be purchased for approximately $6.18.

How big of a company is Livent?

Livent has a market capitalization of $903.39 million and generates $388.40 million in revenue each year. The company earns $50.20 million in net income (profit) each year or $0.42 on an earnings per share basis.

What is Livent's official website?

The official website for Livent is www.livent.com.

How can I contact Livent?

Livent's mailing address is 2929 WALNUT STREET, PHILADELPHIA PA, 19104. The company can be reached via phone at 215-299-6000 or via email at [email protected]

This page was last updated on 7/14/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.